1 |
Lakka, S. S., Rajan, M., Gondi, C., Yanamandra, N., Chandrasekar, N., Jasti, S. L., Adachi, Y., Siddique, K., Gujrati, M., Olivero, W., Dinh, D. H., Kouraklis, G., Kyritsis, A. P. and Rao, J. S. 2002. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene 21, 8011-8019.
DOI
|
2 |
Lu, K. V., Chang, J. P., Parachoniak, C. A., Pandika, M. M., Aghi, M. K., Meyronet, D., Isachenko, N., Fouse, S. D., Phillips, J. J., Cheresh, D. A., Park, M. and Bergers, G. 2012. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell 22, 21-35.
DOI
|
3 |
Min, J. K., Lee, Y. M., Kim, J. H., Kim, Y. M., Kim, S. W., Lee, S. Y., Gho, Y. S., Oh, G. T. and Kwon, Y. G. 2005. Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. Circ. Res. 18, 300-307.
|
4 |
Pupa, S. M., Me‘nard, S., Forti, S. and Tagliabue, E. 2002. New insights into the role of extracellular matrix during tumor onset and progression. J. Cell. Physiol. 192, 259-267.
DOI
|
5 |
Roomi, M. W., Monterrey, J. C., Kalinovsky, T., Rath, M. and Niedzwiecki, A. 2010. Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines. Oncol. Rep. 24, 747-757.
|
6 |
Rosen, E. M., Lamszus, K., Laterra, J., Polverini, P. J., Rubin, J. S. and Goldberg, I. D. 1997. HGF/SF in angiogenesis. Ciba Found Symp. 212, 215-226.
|
7 |
Roth, D., Piekarek, M., Paulsson, M., Christ, H., Bloch, W., Krieg, T., Davidson, J. M. and Eming, S. A. 2006. Plasmin modulates vascular endothelial growth factor-A-mediated angiogenesis during wound repair. Am. J. Pathol. 168, 670-684.
DOI
|
8 |
Vanmeter, T. E., Rooprai, H. K., Kibble, M. M., Fillmore, H. L., Broaddus, W. C. and Pilkington, G. J. 2001. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J. Neuro. Oncol. 53, 213-235.
DOI
|
9 |
Wang, G. M., Kovalenko, B., Huang, Y. and Moscatelli, D. 2007. Vascular endothelial growth factor and angiopoietin are required for prostate regeneration. Prostate 67, 485-499.
DOI
|
10 |
Wick, W., Platten, M. and Weller, M. 2001. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J. Neurooncol. 53, 177-185.
DOI
|
11 |
Xin, X., Yang, S., Ingle, G., Zlot, C., Rangell, L., Kowalski, J., Schwall, R., Ferrara, N. and Gerritsen, M. E. 2001. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am. J. Pathol. 158, 1111-1120.
DOI
|
12 |
Yadav, L., Puri, N., Rastogi, V., Satpute, P. and Sharma, V. 2015. Tumour angiogenesis and angiogenic inhibitors. J. Clin. Diagn. Res. 9, XE01-XE05.
|
13 |
Zachary, I. 2003. VEGF signalling: integration and multi-tasking in endothelial cell biology. Biochem. Soc. Trans. 31, 1171-1177.
DOI
|
14 |
Belotti, D., Paganoni, P., Manenti, L., Garofalo, A., Marchini, S., Taraboletti, G. and Giavazzi, R. 2003. Matrix metalloproteinases(MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res. 63, 5224-5229.
|
15 |
Apoorva, S., Edward, A. S., Archana, V. P., Che, B. P., Brown, M., García, A. J. and Davis, M. E. 2012. Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats. PLoS One 7, e50980.
DOI
|
16 |
Badiga, A. V., Chetty, C., Kesanakurti, D., Are, D., Gujrati, M., Klopfenstein, J. D., Dinh, D. H. and Rao, J. S. 2011. MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS One 6, e20614.
DOI
|
17 |
Bauvois, B. 2012. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim. Biophys. Acta. 1825, 29-36.
|
18 |
Bonnans, C., Chou, J. and Werb, Z. 2014. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell. Biol. 15, 786-801.
|
19 |
Cai, H., Xue, Y., Li, Z., Hu, Y., Wang, Z., Liu, W., Li, Z. and Liu, Y. 2015. Roundabout4 suppresses glioma-induced endothelial cell proliferation, migration and tube formation in vitro by inhibiting VEGR2-mediated PI3K/AKT and FAK signaling pathways. Cell. Physiol. Biochem. 35, 1689-1705.
DOI
|
20 |
Zhang, Y. W., Su, Y., Volpert, O. V. and Vande Woude, G. F. 2002. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc. Natl. Acad. Sci. USA 100, 12718-12723.
|
21 |
Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature 15, 932-936.
|
22 |
Charlesworth, P. J. and Harris, A. L. 2006. Mechanisms of disease: angiogenesis in urologic malignancies. Nat. Clin. Pract. Urol. 3, 157-169.
DOI
|
23 |
Chen, F. X., Qian, Y. R., Duan, Y. H., Ren, W. W., Yang, Y., Zhang, C. C., Qiu, Y. M. and Ji, Y. H. 2009. Down-regulation of 67LR reduces the migratory activity of human glioma cells in vitro. Brain Res. Bull. 14, 402-408.
|
24 |
Choe, G., Park, J. K., Jouben-Steele, L., Kremen, T. J., Liau, L. M., Vinters, H. V., Cloughesy, T. F. and Mischel, P. S. 2002. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin. Cancer Res. 8, 2894-2901.
|
25 |
Cimpean, A. M., Seclaman, E., Ceauşu, R., Gaje, P., Feflea, S., Anghel, A., Raica, M. and Ribatti, D. 2009. VEGF-A/HGF induce Prox-1 expression in the chick embryo chorioallantoic membrane lymphatic vasculature. Clin. Exp. Med. 10, 169-172.
|
26 |
Dzwonek, J., Rylski, M. and Kaczmarek, L. 2004. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett. 567, 129-135.
DOI
|
27 |
Egeblad, M. and Werb, Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174.
DOI
|
28 |
Kesanakurti, D., Chetty, C., Maddirela, D. R., Gujrati, M. and Rao, J. S. 2012. Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma. Cell Death Dis. 3, e445.
DOI
|
29 |
Ferrara, N. 1999. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int. 56, 794-814.
DOI
|
30 |
Guo, P., Imanishi, Y., Cackowski, F. C., Jarzynka, M. J., Tao, H. Q., Nishikawa, R., Hirose, T., Hu, B. and Cheng, S. Y. 2005. Up-Regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5γ2 correlates with the invasiveness of human glioma. Am. J. Pathol. 166, 877-890.
DOI
|
31 |
Klein, S., Giancotti, F. G., Presta, M., Albelda, S. M., Buck, C. A. and Rifkin, D. B. 1993. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol. Biol. Cell 4, 973-982.
DOI
|
32 |
Kleiner, D. E. and Stetler-Stevenson, W. G. 1999. Matrix metalloproteinases and metastasis. Cancer Chemother. Pharmacol. 43, S42-S51.
DOI
|
33 |
Kondraganti, S., Mohanam, S., Chintala, S. K., Kin, Y., Jasti, S. L., Nirmala, C., Lakka, S. S., Adachi, Y., Kyritsis, A. P., Ali-Osman, F., Sawaya, R., Fuller, G. N. and Rao, J. S. 2000. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res. 60, 6851-6855.
|